Shao Jing Tong
Director of Finance/CFO bij REMEGEN CO., LTD.
Profiel
Momenteel bekleedt Shaojing Tong de functie van Chief Financial Officer bij InnoCare Pharma Ltd. De heer Tong zit ook in de raad van bestuur van YishengBio Co, Ltd. Voorheen was de heer Tong Director-Global Research bij Bank of America Merrill Lynch (New York), Research Analyst bij Mehta Partners LLC, Executive Director-Investment Banking Research bij UBS (China) Ltd., Research Analyst bij Merrill Lynch Far East Ltd. en Analyst bij UBS Securities (Asia) Ltd. Shaojing Tong behaalde een MBA aan de New York University, een graduaat aan de University of Pittsburgh en een undergraduaat aan de University of Science & Technology of China.
Actieve functies van Shao Jing Tong
| Bedrijven | Functie | Begin |
|---|---|---|
| REMEGEN CO., LTD. | Director of Finance/CFO | 28-09-2023 |
YishengBio Co., Ltd.
 YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Director/Board Member | - |
Eerdere bekende functies van Shao Jing Tong
| Bedrijven | Functie | Einde |
|---|---|---|
| YS BIOPHARMA CO., LTD. | Director/Board Member | 29-02-2024 |
| INNOCARE PHARMA LIMITED | Director of Finance/CFO | 31-12-2022 |
UBS Securities (Asia) Ltd.
 UBS Securities (Asia) Ltd. Investment Banks/BrokersFinance UBS Securities Asia Ltd. (UBS Asia) is a brokerage firm headquartered in Hong Kong. The firm is a subsidiary of UBS AG, which is owned by UBS Group AG (SWX: UBSG) in Switzerland. UBS Asia provides corporate and institutional clients which include intermediary and alternative asset managers with financial advisory services, access to the world's capital markets and securities products and research in the field of equity, fixed-income, rates, foreign exchange, energy and metals. | Analyst-Equity | 31-05-2019 |
UBS (China) Ltd.
 UBS (China) Ltd. Major BanksFinance Part of UBS Group AG, UBS (China) Ltd. provides retail and commercial banking services. The private company is based in Beijing, China. | Corporate Officer/Principal | 01-05-2019 |
| Bank of America Merrill Lynch (New York) | Corporate Officer/Principal | 01-05-2013 |
Opleiding van Shao Jing Tong
| University of Pittsburgh | Graduate Degree |
| New York University | Masters Business Admin |
| University of Science & Technology of China | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| INNOCARE PHARMA LIMITED | Health Technology |
| REMEGEN CO., LTD. | Health Technology |
| YS BIOPHARMA CO., LTD. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Mehta Partners LLC
 Mehta Partners LLC Investment ManagersFinance Founded in 1980, Mehta Partners LLC is a research firm located in New York City. The universe Mehta monitors includes biopharmaceutical companies in the U.S., Europe, Japan and emerging markets including Brazil, China, Eastern Europe and India. They cover 400 companies that are classified by geography and maturity. | Finance |
Merrill Lynch Far East Ltd.
 Merrill Lynch Far East Ltd. Investment Banks/BrokersFinance Merrill Lynch Far East Ltd. is the stockbroking subsidiary of Merrill Lynch HK Services Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. Headquartered in Hong Kong, the firm was founded in 2003 and offers a broad range of brokerage services to institutional investors. | Finance |
UBS Securities (Asia) Ltd.
UBS Securities (Asia) Ltd. Investment Banks/BrokersFinance UBS Securities Asia Ltd. (UBS Asia) is a brokerage firm headquartered in Hong Kong. The firm is a subsidiary of UBS AG, which is owned by UBS Group AG (SWX: UBSG) in Switzerland. UBS Asia provides corporate and institutional clients which include intermediary and alternative asset managers with financial advisory services, access to the world's capital markets and securities products and research in the field of equity, fixed-income, rates, foreign exchange, energy and metals. | Finance |
| Bank of America Merrill Lynch (New York) | |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Health Technology |
UBS (China) Ltd.
UBS (China) Ltd. Major BanksFinance Part of UBS Group AG, UBS (China) Ltd. provides retail and commercial banking services. The private company is based in Beijing, China. | Finance |
